Mr. Schlissel currently serves as the CEO and President of a diversified in vitro diagnostics company. Prior to that, he had several assignments assisting buyers and sellers engaged in complex carve-out transactions through development and implementation of carve-out plan plans, financial analysis, negotiation and cost reduction programs. Other notable assignments for Mr. Schlissel include serving as Chief Restructuring Advisor to CCS Medical, a $500 million medical device, supply and pharmaceutical distributor for diabetes and other chronic conditions. In this role, he led the effort to restructure CCS's balance sheet and operations including a successful plan of reorganization, arrangement of exit financing, cash management, Chapter 11 bankruptcy process management and organizing the development of short- and long-term strategic plans. He also acted in an interim financial management role for a $350 million global pharmaceutical development company, where he was successful in: restructuring and streamlining the finance and IT organizations; reducing working capital; eliminating significant internal control weaknesses; developing an aggressive operational restructuring plan and transitioning the business through a change in the senior management team.
Prior to joining A&M, Mr. Schlissel was Vice President at Timex Corporation, where he led the launch of a new business venture focused on medical devices and managed the sports and health businesses. Prior to that, he was a Director of Corporate Development and Strategy for Quest Diagnostics, a leading U.S. laboratory service provider, where he led acquisitions, licensing and strategic planning activities.
Mr. Schlissel began his career with KPMG LLP, where he served as a Senior Manager in the Healthcare Audit and Transaction Advisory Services practices leading the management of global audits and financial and operational due diligence assignments for clients in the healthcare, manufacturing and technology industries.
Mr. Schlissel earned a master's degree in business from Columbia Business School and a bachelor's degree in accounting from Binghamton University.